Show simple item record

Authordc.contributor.authorCortés Briones, Jose A.
Authordc.contributor.authorTapia Rivas, Nicolás Igor
Authordc.contributor.authorD'Souza, Deepak Cyril
Authordc.contributor.authorEstévez Valencia, Pablo Antonio
Admission datedc.date.accessioned2022-07-29T14:28:42Z
Available datedc.date.available2022-07-29T14:28:42Z
Publication datedc.date.issued2022
Cita de ítemdc.identifier.citationSchizophrenia Research 245 (2022) 122–140es_ES
Identifierdc.identifier.other10.1016/j.schres.2021.05.018
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/187050
Abstractdc.description.abstractDespite years of research, the mechanisms governing the onset, relapse, symptomatology, and treatment of schizophrenia (SZ) remain elusive. The lack of appropriate analytic tools to deal with the heterogeneity and complexity of SZ may be one of the reasons behind this situation. Deep learning, a subfield of artificial intelligence (AI) inspired by the nervous system, has recently provided an accessible way of modeling and analyzing complex, high-dimensional, nonlinear systems. The unprecedented accuracy of deep learning algorithms in classification and prediction tasks has revolutionized a wide range of scientific fields and is rapidly permeating SZ research. Deep learning has the potential of becoming a valuable aid for clinicians in the prediction, diagnosis, and treatment of SZ, especially in combination with principles from Bayesian statistics. Furthermore, deep learning could become a powerful tool for uncovering the mechanisms underlying SZ thanks to a growing number of techniques designed for improving model interpretability and causal reasoning. The purpose of this article is to introduce SZ researchers to the field of deep learning and review its latest applications in SZ research. In general, existing studies have yielded impressive results in classification and outcome prediction tasks. However, methodological concerns related to the assessment of model performance in several studies, the widespread use of small training datasets, and the little clinical value of some models suggest that some of these results should be taken with caution.es_ES
Patrocinadordc.description.sponsorshipUnited States Department of Health & Human Services National Institutes of Health (NIH) - USA Brain and Behavior Research Foundation Wallace Foundation CH TAC Takeda Pharmaceutical Company Ltd Roche Holding Heffter Research Institute ANID-Chilees_ES
Lenguagedc.language.isoenes_ES
Publisherdc.publisherElsevieres_ES
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
Sourcedc.sourceSchizophrenia Researches_ES
Keywordsdc.subjectSchizophreniaes_ES
Keywordsdc.subjectDeep learninges_ES
Keywordsdc.subjectArtificial intelligencees_ES
Keywordsdc.subjectMachine learninges_ES
Keywordsdc.subjectPsychosises_ES
Keywordsdc.subjectPredictiones_ES
Títulodc.titleGoing deep into schizophrenia with artificial intelligencees_ES
Document typedc.typeArtículo de revistaes_ES
dc.description.versiondc.description.versionVersión publicada - versión final del editores_ES
dcterms.accessRightsdcterms.accessRightsAcceso abiertoes_ES
Catalogueruchile.catalogadorapces_ES
Indexationuchile.indexArtículo de publícación WoSes_ES


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States